Ribavirin was selected into the diagnosis and treatment scheme of COVID-19

Intensifying the research and judgment of anti epidemic drugs is a top priority in the current medical and health front. On February 3, the General Office of the National Health Commission and the Office of the National Administration of Traditional Chinese Medicine jointly issued the Diagnosis and Treatment Plan for Pneumonia Caused by novel coronavirus (Trial Version 5) (hereinafter referred to as the "Diagnosis and Treatment Plan"). The new version of the "Diagnosis and Treatment Plan" is based on the recent development trends of the epidemic and the latest scientific research evidence. On the basis of the fourth version, a series of supplementary revisions have been made to the epidemiological characteristics, clinical manifestations, laboratory tests, treatment, and other contents. Among them, the star drug during the "SARS" period - ribavirin has been included again in the "Diagnosis and Treatment Plan".

In the fifth edition of the "Diagnosis and Treatment Plan", antiviral drug treatment has the following statement: Alternatively, intravenous injection of ribavirin (500mg per dose, twice daily for adults) can be added. According to Zhao Chunjian, General Manager of Zhejiang Cheng Yi Pharmaceutical Co., Ltd., Ribavirin (commonly known as ribavirin) is a broad-spectrum and powerful antiviral drug that has inhibitory effects on many DNA and RNA viruses. Especially during the fight against SARS in 2003, Cheng Yi Pharmaceutical worked overtime to produce ribavirin injections and capsules, donating over 2 million yuan of ribavirin injections and capsules to Guangzhou, Shenzhen, Hong Kong and other southern regions, contributing to the victory of the fight against SARS.

Zhejiang Cheng Yi Pharmaceutical Co., Ltd., located in Wenzhou, Zhejiang, is one of the leading manufacturers of ribavirin in China. Since 2018, its research and production of ribavirin raw materials have won multiple important national and provincial awards. In the face of the epidemic brought about by the novel coronavirus, Cheng Yi Pharmaceutical urgently recalled local employees in Dongtou who were on vacation on the third day of the New Year's Day, and worked overtime to produce ribavirin injections and capsules, which will be used to rescue key areas and the front line of the "epidemic".

Source: Wenzhou Municipal Bureau of Science and Technology